Closing the Yamanaka lab at Gladstone

The most important early sale was the Yamanaka lab at Gladstone Institutes. Shinya Yamanaka won the Nobel Prize in Physiology or Medicine in 2012 for discovering how to reprogram mature cells into stem cells. His lab does not use tools it does not trust.

Closing it meant flying to Japan and selling into one of the most demanding research environments in the world. This was not a team that would tolerate hand-waving about data integrity or workflow reliability. They needed to see it work on their own data, in their own environment, with their own edge cases.

The deal mattered beyond the revenue. It became the proof point we reached for every time another research team asked whether Colabra actually worked in production. Not in a demo. Not on sample data. In a Nobel laureate's lab, on real experiments, at Gladstone.